埃索美拉唑
泮托拉唑
烧心
格尔德
医学
胃肠病学
内科学
回流
随机对照试验
奥美拉唑
疾病
作者
Aleksandar Včev,Ivana Begić,Rajko Ostojić,Dragan Jurčić,Dusan Bozic,Ivan Soldo,Rudika Gmajnić,Goran Kondza,Eyad Khaznadar,Nikola Mićunović
摘要
The aim of this study was to compare the efficacy of esomeprazole and pantoprazole with regard to healing and relief from gastroesophageal reflux disease-related symptoms. I this multicentre, randomized, single-blind study 180 patients (ITT population) diagnosed with endoscopically proven GERD grade A,B,C received esomeprazole (40 mg once daily (o.d.), n = 90) orpantoprazole (40 mg o.d., n = 90). Healing and relief from GERD-related symptoms were assessed at first and final visit (after 4 or 8 weeks of treatment). Esomeprazole 40 mg provided significantly greater healing than pantoprazole 40 mg after 4 weeks of treatment in patients with EE (77.8% vs. 72.2%). Esomeprazole-treated patients were healed after up to 8 weeks of treatment similar those treated with pantoprazole (92.2% vs. 91.1%). The proportion of heartburn-free days was similar in patients treated with esomeprazole and to those treated with pantoprazole.
科研通智能强力驱动
Strongly Powered by AbleSci AI